While control B16-F10 tumors showed consistent cell growth inhibition upon α-PD-1 treatment, IκBζ-overexpressing B16-F10 tumors retained tumor growth (Fig. 6b, c). This evidence concerns the gene NFKBIZ and neoplasm.